Non-Ionizing 6G Signals Accurately Classify Lung Diseases Without Contact
January 7, 2026
Brand Name :
alinia
Synonyms :
Nitazoxanide, Nitazoxanida
Class :
Anti-parasitic
Dosage Forms & Strengths
Tablet
500mg
Oral suspension
100mg/5ml
500
mg
Tablet
Orally
every 12 hrs
3
days
Dosage Forms & Strengths
Tablet
500mg
Oral suspension
100mg/5ml
<1 year: Safety and efficacy not established
1-3 years:5 ml orally every 12 hours for three days
4-11 years: 10 ml orally every 12 hours for three days
>12 years: 500mg orally every 12 hours for three days
It may enhance the immunosuppressive effects when combined with idecabtagene vicleucel
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
Frequency defined:
1-10%
Abdominal pain
Nausea
Vomiting
Headache
Diarrhea
Chromaturia
<1%
Anorexia
Increased levels of creatinine
Dizziness
Fever
Infection
Pruritis
Enlarged salivary glands
Increased ALT
Increased appetite
Diaphoresis
Eye discoloration
Flatulence
Thinitis
Post-marketing reports
Dizziness
Rash
Diarrhea
dyspnea
Pregnancy consideration: Insufficient data available
Lactation: Excretion of the drug in human breast milk is unknown
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient information leaflet
Generic Name: nitazoxanide
Pronounced: [ NYE-ta-ZOX-a-nide ]
Why do we use nitazoxanide?
It is used to treat diarrhea caused by giardia